Compare INCY & PAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | INCY | PAG |
|---|---|---|
| Founded | 1991 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Retail-Auto Dealers and Gas Stations |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.0B | 14.2B |
| IPO Year | 1994 | 1996 |
| Metric | INCY | PAG |
|---|---|---|
| Price | $124.82 | $216.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 8 |
| Target Price | $103.52 | ★ $183.50 |
| AVG Volume (30 Days) | ★ 1.3M | 297.4K |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 3.26% |
| EPS Growth | ★ 4173.33 | 2.84 |
| EPS | 1.47 | ★ 7.52 |
| Revenue | ★ $3,394,635,000.00 | N/A |
| Revenue This Year | $10.44 | $0.83 |
| Revenue Next Year | $10.99 | $4.31 |
| P/E Ratio | $83.82 | ★ $28.80 |
| Revenue Growth | ★ 13.67 | N/A |
| 52 Week Low | $81.09 | $140.12 |
| 52 Week High | $132.60 | $227.00 |
| Indicator | INCY | PAG |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 56.01 |
| Support Level | $92.37 | $216.14 |
| Resistance Level | $131.70 | $220.55 |
| Average True Range (ATR) | 3.05 | 2.68 |
| MACD | -0.52 | -1.17 |
| Stochastic Oscillator | 50.98 | 21.42 |
Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Penske Automotive Group operates in 19 US states and overseas. It has about 150 US and Puerto Rico light-vehicle stores as well as 217 franchised dealerships overseas, primarily in the United Kingdom but also in Australia, Germany, Italy, and Japan. The company is the third-largest US publicly traded dealership in terms of light-vehicle revenue and sells more than 40 brands, with over 90% of retail automotive revenue coming from luxury and import names. Other segments are service and finance and insurance. The firm's Premier Truck Group owns 45 truck dealerships selling mostly Freightliner and Western Star brands, and Penske owns 15 used-vehicle stores, mostly in the US and UK under the CarShop (US) and Sytner Select (UK) brands. Penske is based in Bloomfield Hills, Michigan.